We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+47.5%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
–
Cap. Flow
+$245M
Cap. Flow %
91.48%
Top 10 Hldgs %
25%
Holding
94
New
94
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IRD
Opus Genetics
IRD
+$14.3M
2
ANAB icon
AnaptysBio
ANAB
+$6.34M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$5.78M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$5.47M
5
INSM icon
Insmed
INSM
+$5.43M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 85.32%
2 Technology 2.23%
3 Consumer Staples 1.19%
4 Financials 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENT
51
DELISTED
Intersect ENT, Inc
XENT
$2.28M 0.85%
+99,661
New +$1.9M
TLSA icon
52
Tiziana Life Sciences
TLSA
$127M
$2.18M 0.81%
+1,077,883
New +$3.41M
SYRE icon
53
Spyre Therapeutics
SYRE
$9.25B
$2.11M 0.79%
+10,710
New +$2.22M
EPIX
54
DELISTED
ESSA Pharma
EPIX
$2.09M 0.78%
+175,067
New +$1.23M
TVTX icon
55
Travere Therapeutics
TVTX
$5.78B
$2.08M 0.78%
+76,484
New +$1.79M
KPTI icon
56
Karyopharm Therapeutics
KPTI
$48M
$2.07M 0.77%
+8,930
New +$2.07M
JYAC
57
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$2.06M 0.77%
+200,000
New +$2.04M
GMED icon
58
Globus Medical
GMED
$11.2B
$2.06M 0.77%
+31,512
New +$1.81M
DXCM icon
59
DexCom
DXCM
$32B
$2.03M 0.76%
+22,000
New +$1.96M
ONCT
60
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$2.02M 0.75%
+20,583
New +$1.3M
ICUI icon
61
ICU Medical
ICUI
$4.61B
$2M 0.75%
+9,321
New +$1.81M
RIGL icon
62
Rigel Pharmaceuticals
RIGL
$750M
$2M 0.75%
+57,103
New +$1.65M
LRMR icon
63
Larimar Therapeutics
LRMR
$432M
$2M 0.75%
+93,261
New +$1.87M
GYRE icon
64
Gyre Therapeutics
GYRE
$744M
$1.98M 0.74%
+41,833
New +$1.81M
OTIC
65
DELISTED
Otonomy, Inc.
OTIC
$1.94M 0.72%
+299,890
New +$1.36M
OPTN
66
DELISTED
OptiNose
OPTN
$1.9M 0.71%
+30,573
New +$1.87M
CTIC
67
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$1.9M 0.71%
+588,992
New +$1.96M
BCRX icon
68
BioCryst Pharmaceuticals
BCRX
$2.4B
$1.86M 0.7%
+250,000
New +$1.29M
OPENW
69
DELISTED
Opendoor Technologies Inc Warrants expiring 12/18/2025
OPENW
$1.85M 0.69%
+240,000
New +$1.75M
CTMX icon
70
CytomX Therapeutics
CTMX
$754M
$1.79M 0.67%
+273,703
New +$1.96M
CLRB icon
71
Cellectar Biosciences
CLRB
$20.5M
$1.77M 0.66%
+2,840
New +$1.31M
ARQT icon
72
Arcutis Biotherapeutics
ARQT
$3.18B
$1.77M 0.66%
+62,962
New +$1.54M
HARP
73
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1.69M 0.63%
+10,199
New +$1.58M
SBE.WS
74
DELISTED
Switchback Energy Acquisition Corporation Warrants, exercisable for one share of Class A Common Stoc
SBE.WS
$1.62M 0.6%
+105,000
New +$877K
EPZM
75
DELISTED
Epizyme, Inc
EPZM
$1.41M 0.53%
+130,000
New +$1.6M
1 2
3
4

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Altium Capital Management, which disclosed 94 positions worth $268M. Its ten largest holdings account for 25% of the portfolio.

Its largest position is Opus Genetics: 2,068,530 shares worth $13.4M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, followed by Technology and Consumer Staples.

  • Altium Capital Management's largest Q4 2020 buy was Opus Genetics: 2,068,530 shares worth $13.4M.
  • Altium Capital Management's ten largest holdings make up 25% of its $268M portfolio in Q4 2020.
  • Altium Capital Management disclosed 94 positions in Q4 2020, its first 13F filing on record.

Based on Altium Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.